BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37682095)

  • 41. A Cross-Talk between the Erythrocyte L-Arginine/ADMA/Nitric Oxide Metabolic Pathway and the Endothelial Function in Subjects with Type 2 Diabetes Mellitus.
    Gajecki D; Gawryś J; Wiśniewski J; Fortuna P; Szahidewicz-Krupska E; Doroszko A
    Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The global burden of cerebral small vessel disease related to neurological deficit severity and clinical outcomes of acute ischemic stroke after IV rt-PA treatment.
    Liu X; Li T; Diao S; Cai X; Kong Y; Zhang L; Wang Z; Li R; Zhou Y; Fang Q
    Neurol Sci; 2019 Jun; 40(6):1157-1166. PubMed ID: 30830567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. L-arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat.
    Morikawa E; Moskowitz MA; Huang Z; Yoshida T; Irikura K; Dalkara T
    Stroke; 1994 Feb; 25(2):429-35. PubMed ID: 7508154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ambulatory blood pressure in patients with lacunar stroke: association with total MRI burden of cerebral small vessel disease.
    Klarenbeek P; van Oostenbrugge RJ; Rouhl RP; Knottnerus IL; Staals J
    Stroke; 2013 Nov; 44(11):2995-9. PubMed ID: 23982717
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of glymphatic-meningeal lymphatic system with intravenous gadolinium-based contrast-enhancement in cerebral small-vessel disease.
    Zhang M; Tang J; Xia D; Xue Y; Ren X; Huang Q; Shi L; Tang W; Fu J
    Eur Radiol; 2023 Sep; 33(9):6096-6106. PubMed ID: 37410111
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the Contribution of Myelin Content in Normal Appearing White Matter to Cognitive Outcomes in Cerebral Small Vessel Disease.
    Dao E; Tam R; Hsiung GR; Ten Brinke L; Crockett R; Barha CK; Yoo Y; Al Keridy W; Doherty SH; Laule C; MacKay AL; Liu-Ambrose T
    J Alzheimers Dis; 2021; 80(1):91-101. PubMed ID: 33523006
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Higher Cerebral Small Vessel Disease Burden in Patients with White Matter Recent Small Subcortical Infarcts.
    Rudilosso S; Mena L; Esteller D; Olivera M; Mengual JJ; Montull C; Castrillo L; Urra X; Gómez-Choco M
    J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105824. PubMed ID: 33906070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of the nitric oxide synthesis inhibitor L-NAME on amitriptyline-induced hypotension in rats.
    Tuncok Y; Kalkan S; Murat N; Arkan F; Guven H; Aygoren O; Kurt S
    J Toxicol Clin Toxicol; 2002; 40(2):121-7. PubMed ID: 12126183
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypercholesterolemia induced cerebral small vessel disease.
    Kraft P; Schuhmann MK; Garz C; Jandke S; Urlaub D; Mencl S; Zernecke A; Heinze HJ; Carare RO; Kleinschnitz C; Schreiber S
    PLoS One; 2017; 12(8):e0182822. PubMed ID: 28796818
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impaired dynamic cerebral autoregulation is associated with the severity of neuroimaging features of cerebral small vessel disease.
    Liu Z; Ma H; Guo ZN; Wang L; Qu Y; Fan L; Liu X; Liu J; Zhu Y; Yang Y
    CNS Neurosci Ther; 2022 Feb; 28(2):298-306. PubMed ID: 34894087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of endothelial nitric oxide synthase in the cerebral hemodynamics after controlled cortical impact injury in mice.
    Hlatky R; Lui H; Cherian L; Goodman JC; O'Brien WE; Contant CF; Robertson CS
    J Neurotrauma; 2003 Oct; 20(10):995-1006. PubMed ID: 14588116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitric oxide synthase inhibition and extracellular glutamate concentration after cerebral ischemia/reperfusion.
    Zhang J; Benveniste H; Klitzman B; Piantadosi CA
    Stroke; 1995 Feb; 26(2):298-304. PubMed ID: 7530389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spontaneous white matter damage, cognitive decline and neuroinflammation in middle-aged hypertensive rats: an animal model of early-stage cerebral small vessel disease.
    Kaiser D; Weise G; Möller K; Scheibe J; Pösel C; Baasch S; Gawlitza M; Lobsien D; Diederich K; Minnerup J; Kranz A; Boltze J; Wagner DC
    Acta Neuropathol Commun; 2014 Dec; 2():169. PubMed ID: 25519173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Negative correlation between serum pyruvate kinase M2 and cognitive function in patients with cerebral small vessel disease.
    Bian L; Zhou Y; Zhang D; Jiang T; Xing C; Wu X; Wang T; Zhu X
    Clin Neurol Neurosurg; 2023 Feb; 225():107586. PubMed ID: 36641992
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Triglyceride glucose index is associated with cerebral small vessel disease burden and cognitive impairment in elderly patients with type 2 diabetes mellitus.
    Teng Z; Feng J; Dong Y; Xu J; Jiang X; Chen H; Qi Q; Li R; Chen W; Lv P
    Front Endocrinol (Lausanne); 2022; 13():970122. PubMed ID: 35992100
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optical coherence tomography-based assessment of retinal vascular pathology in cerebral small vessel disease.
    Abdelhak A; Huss A; Brück A; Sebert U; Mayer B; Müller HP; Tumani H; Otto M; Yilmazer-Hanke D; Ludolph AC; Kassubek J; Pinkhardt E; Neugebauer H
    Neurol Res Pract; 2020; 2():13. PubMed ID: 33324919
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Serum Cystatin C With Cerebral Small Vessel Disease in Community-Based Population.
    Yao D; Li S; Jing J; Cai X; Jin A; Yang Y; Wang S; Meng X; Lin J; Mei L; Li H; Wei T; Wang Y; Pan Y; Wang Y
    Stroke; 2022 Oct; 53(10):3123-3132. PubMed ID: 35862202
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury.
    Gu Y; Zheng G; Xu M; Li Y; Chen X; Zhu W; Tong Y; Chung SK; Liu KJ; Shen J
    J Neurochem; 2012 Jan; 120(1):147-56. PubMed ID: 22007835
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effects of left heart function changes on cerebral small vessel diseases and its cognitive impairment].
    Zhao W; Zhu XQ; Liu H; Tong XX; Wu YL; Zhang H; Zhou X; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(13):971-976. PubMed ID: 30955307
    [No Abstract]   [Full Text] [Related]  

  • 60. Associations of Blood Pressure and Carotid Flow Velocity with Brain Volume and Cerebral Small Vessel Disease in a Community-Based Population.
    Chuang SY; Wang PN; Chen LK; Chou KH; Chung CP; Chen CH; Mitchell GF; Pan WH; Cheng HM
    Transl Stroke Res; 2021 Apr; 12(2):248-258. PubMed ID: 32737795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.